艾司氯胺酮用于患者自控静脉镇痛对老年全髋或全膝关节置换术后睡眠障碍的影响:一项前瞻性、随机、双盲、对照试验
该前瞻性随机双盲对照试验纳入120例老年全髋或全膝关节置换患者,比较艾司氯胺酮(0.72 mg kg-1)联合舒芬太尼与单纯舒芬太尼PCIA对术后睡眠障碍的影响。结果显示艾司氯胺酮组术后第1、2、3天睡眠障碍发生率更低,焦虑抑郁评分更低,术后恢复更好,48小时内补救镇痛更少,认知功能、谵妄及不良事件无显著差异。
要点
- 艾司氯胺酮组术后第1、2、3天睡眠障碍发生率均低于舒芬太尼组。
- 艾司氯胺酮组术后第1、2、3天焦虑抑郁评分更低,术后恢复更好。
- 两组术后认知功能、谵妄发生率及不良事件无显著差异。
核心结论
- 艾司氯胺酮(0.72 mg kg-1)用于PCIA可安全预防老年全髋或全膝关节置换患者的术后睡眠障碍,改善镇痛,缓解焦虑抑郁,加速术后恢复。
研究设计与样本
- 前瞻性、随机、双盲、对照试验,纳入120例接受全髋或全膝关节置换的老年患者,随机分为患者自控舒芬太尼镇痛组(2 μg kg-1溶于生理盐水至100 mL)或加用艾司氯胺酮(0.72 mg kg-1)组,符合方案分析纳入112例。
主要发现
- 术后第1天睡眠障碍发生率艾司氯胺酮组低于舒芬太尼组(P = 0.002),术后第2天(P = 0.018)和术后第3天(P = 0.025)也低于舒芬太尼组。
- 与舒芬太尼组相比,艾司氯胺酮组术后第1、2、3天焦虑和抑郁评分更低(P < 0.05),术后恢复更好(P < 0.05),48小时内补救镇痛更少(P = 0.016)。
- 两组术后认知功能(P > 0.05)、术后谵妄发生率(P > 0.05)及不良事件无显著差异。
关键数值与推荐
- 术后睡眠障碍定义为数字评定量表评分≥6分或雅典失眠量表评分≥6分。
- 主要结局为术后第1天睡眠障碍发生率;次要结局包括术后第2、3、7天睡眠障碍发生率、术后主观睡眠质量、焦虑抑郁、认知功能、PCIA尝试次数、48小时内补救镇痛、术后谵妄及恢复质量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative sleep disturbance (PSD) commonly affects elderly patients, impairing recovery. This study investigated the effect of esketamine for patient-controlled intravenous analgesia (PCIA) on PSD in elderly patients who had total hip arthroplasty (THA) or total knee arthroplasty (TKA). METHODS: In this trial, 120 elderly patients who underwent THA or TKA were randomized to patient-controlled sufentanil analgesia (2 μg kg-1 in normal saline to 100 mL) or a supplement (esketamine 0.72 mg kg-1). The primary outcome was the incidence of PSD on postoperative day (POD) 1. Postoperative sleep disturbance (PSD) was defined as a numeric rating scale score of 6 or higher or an Athens Insomnia Scale score of 6 or higher. The secondary outcomes included the incidence of PSD on postoperative days two, three, and seven; postoperative subjective sleep quality, anxiety and depression, cognitive function, the number of PCIA attempts, rescue analgesics within 48 hours, postoperative delirium, and quality of recovery. Also, nausea and vomiting and other adverse events were compared. There were 112 patients included in the per-protocol analysis. RESULTS: The incidence of PSD was lower in the esketamine group compared to the sufentanil group on POD one (P = 0.002), POD two (P = 0.018), and POD three (P = 0.025). Compared with the sufentanil group, the esketamine group had lower anxiety and depression scores on postoperative days one, two, and three (P < 0.05), better postoperative recovery (P < 0.05), and fewer rescue analgesics within 48 hours (P = 0.016). There were no significant differences in postoperative cognitive function (P > 0.05), incidence of postoperative delirium (P > 0.05), and adverse events between the two groups. CONCLUSIONS: Esketamine (0.72 mg kg-1) in PCIA safely prevents PSD, improves analgesia, relieves anxiety and depression, and accelerates postoperative recovery in elderly patients who had THA or TKA.
引用
- Zhao Y, Ye C, He Y, et al. Effect of Esketamine for Patient-Controlled Intravenous Analgesia on Postoperative Sleep Disturbance in the Elderly After Total Hip or Knee Arthroplasty: A Prospective, Randomized, Double-Blind, and Controlled Trial. J Arthroplasty. 2025. PMID: 40484051. doi:10.1016/j.arth.2025.06.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。